Cures & Capital
Hello and welcome to Cures & Capital - the podcast on value creation in biotech and pharma.
Together, we are going to dive deep into the world of biotech and pharma to tackle the holy grail - how do we improve return on investment from drug innovation and deliver transformative therapies to patients, efficiently and sustainably.
Hosted by Martin Slezak & Simon Birksø
Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.
Cures & Capital
Matthias Krings on crafting winning biopharma strategies and smart decisions
In this episode, our guest is Dr. Matthias Krings - a senior partner at Catenion, a biopharma strategy consulting firm.
Matthias is a seasoned veteran in biopharma strategy.
In this conversation, he shares his playbook for achieving success as a biopharma company.
As critical pillars for biopharma success, we dive into strategy processes, decision-making, and effective R&D risk management.
If you want to connect with us - we would love to hear from you:
LinkedIn: https://www.linkedin.com/company/cures-capital-podcast
You can also watch the full episode on our YouTube channel.
Get in touch with Catenion: www.catenion.com
You can get in touch with Matthias through the Catenion website or via LinkedIn.
Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.
